Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Biochem Pharmacol. 2021 Feb 10;186:114462. doi: 10.1016/j.bcp.2021.114462

Table 1.

Effects of flavonoids and CDK9 inhibitors on active HIV replication and cell viability in PBMCs.

Compound EC50 (μM) CC50 (μM) Selectivity Index
(CC50/EC50)
Chrysin 9.2 ± 2.9 > 30 > 3.3
Apigenin 5.0 ± 1.6 19.8 ± 6.5 4.0
Luteolin 12.7 ± 3.2 13.9 ± 5.9 1.1
L7G 2.6 ± 0.8 18.3 ± 2.5 7.0
Naringenin > 30 > 30 n.d.
Flavopiridol 0.020 ± 0.003 0.22 ± 0.04 11.0
Atuveciclib 3.4 ± 0.67 24.4 ± 1.5 7.2